Immune checkpoint inhibitors (anti PD‐1 or anti PD‐L1) versus chemotherapy for second‐ or third‐line treatment of metastatic non‐small cell lung cancer

This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To evaluate the effectiveness and safety of immune checkpoint inhibitors (anti PD‐1 or anti PD‐L1) compared with standard chemotherapy for second‐ or third‐line treatment of metastatic non‐small cell lung cancer...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cochrane Database Syst Rev
Main Authors: Moraes, Fabio Y, Perry, Luke A, Penny‐Dimri, Jahan C, Ramson, Dhruvesh, de Castria, Tiago B, Bowman, Rayleen V, Santos, Fábio N, Fong, Kwun M, Riera, Rachel
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley & Sons, Ltd 2017
Assuntos:
Medicine General & Introductory Medical Sciences
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6478330/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD012644
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados